MHRA OKs Celltrion’s Phase I trial of COVID drug July 31, 2020 Auto Bot News 0 The trial will enrol patients with mild symptoms of SARS-CoV-2 infection to evaluate the safety, tolerability, efficacy, pharmacokinetics and immunogenicity of CT-P59